• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Announcements


CGB Supplementary Prospectus22/03/19
CGB Supplementary Prospectus22/02/19
CGB Supplementary Prospectus08/02/19
CGB STRATEGIC ALLIANCE WITH TGA & GMP APPROVED MANUFACTURERPRICE SENSITIVE08/02/19
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/02/19
CGB Supplementary Prospectus25/01/19
CGB Change of name to Cann Global Limited25/01/19
CGB Clarification on earlier ASX waiver announcement17/01/19
CGB ASX APPROVAL LETTER AND TERMS OF ASX WAIVERS14/01/19
CGB Cover Letter and Supplementary Prospectus24/12/18
CGB Cover Note to Supplementary Prospectus and Relisting Update21/12/18
CGB Supplementary Prospectus14/12/18
CGB Supplementary Prospectus07/12/18
CGB Supplementary Prospectus28/11/18
CGB Results of Federal Court Hearing27/11/18
CGB Results of AGM27/11/18
CGB Appendix 3B and Cover Note26/11/18
CGB Fourth Supplementary Prospectus - Updated Timetable14/11/18
CGB Third Supplementary Prospectus - updated timetable07/11/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/10/18
CGB Cover Note and Second Supplementary Prospectus31/10/18
CGB Notice of Annual General Meeting/Proxy Form29/10/18
CGB Strategic Collaboration Supply Agreement with Canadian LPPRICE SENSITIVE24/10/18
CGB Annual Report to shareholders23/10/18
CGB JV WITH LEADING ISRAELI CANNABIS COMPANY PHARMOCANNPRICE SENSITIVE19/10/18
CGB Cover Note and Supplementary ProspectusPRICE SENSITIVE18/10/18
CGB ODC MANUFACTURE LICENCE SECUREDPRICE SENSITIVE09/10/18
CGB Prospectus and Cover NotePRICE SENSITIVE01/10/18
CGB Recompliance ProspectusPRICE SENSITIVE28/09/18
CGB Results of Meeting14/09/18
CGB Chairperson's cover letter to the notice of meeting22/08/18
CGB QBL to Acquire International Health Food BrandsPRICE SENSITIVE16/08/18
CGB Notice of Extraordinary General Meeting/Proxy Form16/08/18
CGB Suspension Announcement - System UpgradePRICE SENSITIVE06/08/18
CGB Ground-breaking Discovery in Medicinal Cannabis Research01/08/18
CGB Suspension from Official QuotationPRICE SENSITIVE01/08/18
CGB Recompliance UpdatePRICE SENSITIVE01/08/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/08/18
CGB Suspension from Official QuotationPRICE SENSITIVE01/08/18
CGB Trading HaltPRICE SENSITIVE30/07/18
CGB MEDICAL CANNABIS IMPORT & EXPORT LICENCES SECUREDPRICE SENSITIVE18/07/18
CGB Revised Timetable for Recompliance16/07/18
CGB Queensland Bauxite Shareholder Q and A13/07/18
CGB Open Letter From The Chairperson of QBL02/07/18
CGB Corporate Governance Statement29/06/18
CGB Q&A on the merger of QBL MCL and Medcan22/06/18
CGB Reinstatement to Official QuotationsPRICE SENSITIVE20/06/18
CGB COMPANY TRANSFORMATION ANNOUNCEMENTPRICE SENSITIVE20/06/18
CGB QBL to Recommence Trading on Thursday 21st June18/06/18
CGB Resumption of Trading of QBL08/06/18
CGB Update on Resumption of Trading01/06/18
CGB Voluntary Suspension Extension Request25/05/18
CGB Suspension Extension Request17/05/18
CGB Request For Voluntary Suspension extension 7 days09/05/18
CGB Suspension Extension Request07/05/18
CGB Suspension from Official QuotationPRICE SENSITIVE04/05/18
CGB Trading HaltPRICE SENSITIVE02/05/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/05/18
CGB QBL BAUXITE TEAM IN CHINA26/04/18
CGB MCL secures access to Medical Cannabis import licensePRICE SENSITIVE20/04/18
CGB Coles Now Selling Hemp Products Provided by MCLPRICE SENSITIVE19/04/18
CGB MCL First to Release Australian Hemp Seed Oil CapsulesPRICE SENSITIVE18/04/18
CGB MCL Implementing Canntab Drug Development StrategyPRICE SENSITIVE29/03/18
CGB Cover Letter to Appendix 3B 19 03 201820/03/18
CGB Half Year Report and Accounts19/03/18
CGB Appendix 3B19/03/18
CGB A WORLD FIRST FOR MCL IN AUTOIMMUNE DISEASE RESEARCHPRICE SENSITIVE26/02/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/02/18
CGB John Easterling -Amazon John- To Join Board of MCL18/01/18
CGB Reinstatement to official quotationPRICE SENSITIVE08/01/18
CGB MCL LEADS IN MEDICAL CANNABIS WITH CANADIAN DEALPRICE SENSITIVE08/01/18
CGB Request for Voluntary Suspension08/01/18
CGB Suspension from Official QuotationPRICE SENSITIVE08/01/18
CGB Request for Trading Halt04/01/18
CGB Trading HaltPRICE SENSITIVE04/01/18
CGB MCL Escalates Hemp Seed Food ProductionPRICE SENSITIVE27/12/17
CGB MCL and AEB join to develop Cannabis veterinary medications22/12/17
CGB MCL and AEB join to develop Cannabis veterinary medicationsPRICE SENSITIVE22/12/17
CGB Trading HaltPRICE SENSITIVE20/12/17
CGB Breakthrough for GMP Quality Medicinal CannabisPRICE SENSITIVE11/12/17
CGB South Johnstone Project UpdatePRICE SENSITIVE08/12/17
CGB Australias largest hemp food production underwayPRICE SENSITIVE07/12/17
CGB VitaHemp Product Launch Australian Grown GoodnessPRICE SENSITIVE27/11/17
CGB Momentous Deal with Premium Hemp Processing GroupPRICE SENSITIVE22/11/17
CGB Results of AGM15/11/17
CGB HISTORIC MOMENT FOR QBLPRICE SENSITIVE13/11/17
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/10/17
CGB Anticipated Cashflow from MCL InvestmentPRICE SENSITIVE27/10/17
CGB Engagement of Israeli Medical Cannabis Research OrganisationPRICE SENSITIVE16/10/17
CGB MDL Granted on South Johnstone Bauxite ProjectPRICE SENSITIVE16/10/17
CGB Notice of Annual General Meeting/Proxy Form11/10/17
CGB Response to ASX price and volume queryPRICE SENSITIVE09/10/17
CGB Notice of Issue of Performance Shares04/10/17
CGB Annual Report to shareholders29/09/17
CGB Appendix 4G29/09/17
CGB Appendix 3B29/09/17
CGB Preparing Major Launch of MCL's Quality Vitahemp ProductsPRICE SENSITIVE26/09/17
CGB Unique Variations and High Levels of Cannabinoids IdentifiedPRICE SENSITIVE19/09/17
CGB MDL Work Programme ApprovedPRICE SENSITIVE13/09/17
CGB Results of General Meeting12/09/17
CGB Supplementary Prospectus
22/03/19
CGB Supplementary Prospectus
22/02/19
CGB Supplementary Prospectus
08/02/19
CGB STRATEGIC ALLIANCE WITH TGA & GMP APPROVED MANUFACTURER
08/02/19PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/02/19PRICE SENSITIVE
CGB Supplementary Prospectus
25/01/19
CGB Change of name to Cann Global Limited
25/01/19
CGB Clarification on earlier ASX waiver announcement
17/01/19
CGB ASX APPROVAL LETTER AND TERMS OF ASX WAIVERS
14/01/19
CGB Cover Letter and Supplementary Prospectus
24/12/18
CGB Cover Note to Supplementary Prospectus and Relisting Update
21/12/18
CGB Supplementary Prospectus
14/12/18
CGB Supplementary Prospectus
07/12/18
CGB Supplementary Prospectus
28/11/18
CGB Results of Federal Court Hearing
27/11/18
CGB Results of AGM
27/11/18
CGB Appendix 3B and Cover Note
26/11/18
CGB Fourth Supplementary Prospectus - Updated Timetable
14/11/18
CGB Third Supplementary Prospectus - updated timetable
07/11/18
CGB Quarterly Activities and Cashflow Report
31/10/18PRICE SENSITIVE
CGB Cover Note and Second Supplementary Prospectus
31/10/18
CGB Notice of Annual General Meeting/Proxy Form
29/10/18
CGB Strategic Collaboration Supply Agreement with Canadian LP
24/10/18PRICE SENSITIVE
CGB Annual Report to shareholders
23/10/18
CGB JV WITH LEADING ISRAELI CANNABIS COMPANY PHARMOCANN
19/10/18PRICE SENSITIVE
CGB Cover Note and Supplementary Prospectus
18/10/18PRICE SENSITIVE
CGB ODC MANUFACTURE LICENCE SECURED
09/10/18PRICE SENSITIVE
CGB Prospectus and Cover Note
01/10/18PRICE SENSITIVE
CGB Recompliance Prospectus
28/09/18PRICE SENSITIVE
CGB Results of Meeting
14/09/18
CGB Chairperson's cover letter to the notice of meeting
22/08/18
CGB QBL to Acquire International Health Food Brands
16/08/18PRICE SENSITIVE
CGB Notice of Extraordinary General Meeting/Proxy Form
16/08/18
CGB Suspension Announcement - System Upgrade
06/08/18PRICE SENSITIVE
CGB Ground-breaking Discovery in Medicinal Cannabis Research
01/08/18
CGB Suspension from Official Quotation
01/08/18PRICE SENSITIVE
CGB Recompliance Update
01/08/18PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/08/18PRICE SENSITIVE
CGB Suspension from Official Quotation
01/08/18PRICE SENSITIVE
CGB Trading Halt
30/07/18PRICE SENSITIVE
CGB MEDICAL CANNABIS IMPORT & EXPORT LICENCES SECURED
18/07/18PRICE SENSITIVE
CGB Revised Timetable for Recompliance
16/07/18
CGB Queensland Bauxite Shareholder Q and A
13/07/18
CGB Open Letter From The Chairperson of QBL
02/07/18
CGB Corporate Governance Statement
29/06/18
CGB Q&A on the merger of QBL MCL and Medcan
22/06/18
CGB Reinstatement to Official Quotations
20/06/18PRICE SENSITIVE
CGB COMPANY TRANSFORMATION ANNOUNCEMENT
20/06/18PRICE SENSITIVE
CGB QBL to Recommence Trading on Thursday 21st June
18/06/18
CGB Resumption of Trading of QBL
08/06/18
CGB Update on Resumption of Trading
01/06/18
CGB Voluntary Suspension Extension Request
25/05/18
CGB Suspension Extension Request
17/05/18
CGB Request For Voluntary Suspension extension 7 days
09/05/18
CGB Suspension Extension Request
07/05/18
CGB Suspension from Official Quotation
04/05/18PRICE SENSITIVE
CGB Trading Halt
02/05/18PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/05/18PRICE SENSITIVE
CGB QBL BAUXITE TEAM IN CHINA
26/04/18
CGB MCL secures access to Medical Cannabis import license
20/04/18PRICE SENSITIVE
CGB Coles Now Selling Hemp Products Provided by MCL
19/04/18PRICE SENSITIVE
CGB MCL First to Release Australian Hemp Seed Oil Capsules
18/04/18PRICE SENSITIVE
CGB MCL Implementing Canntab Drug Development Strategy
29/03/18PRICE SENSITIVE
CGB Cover Letter to Appendix 3B 19 03 2018
20/03/18
CGB Half Year Report and Accounts
19/03/18
CGB Appendix 3B
19/03/18
CGB A WORLD FIRST FOR MCL IN AUTOIMMUNE DISEASE RESEARCH
26/02/18PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/02/18PRICE SENSITIVE
CGB John Easterling -Amazon John- To Join Board of MCL
18/01/18
CGB Reinstatement to official quotation
08/01/18PRICE SENSITIVE
CGB MCL LEADS IN MEDICAL CANNABIS WITH CANADIAN DEAL
08/01/18PRICE SENSITIVE
CGB Request for Voluntary Suspension
08/01/18
CGB Suspension from Official Quotation
08/01/18PRICE SENSITIVE
CGB Request for Trading Halt
04/01/18
CGB Trading Halt
04/01/18PRICE SENSITIVE
CGB MCL Escalates Hemp Seed Food Production
27/12/17PRICE SENSITIVE
CGB MCL and AEB join to develop Cannabis veterinary medications
22/12/17
CGB MCL and AEB join to develop Cannabis veterinary medications
22/12/17PRICE SENSITIVE
CGB Trading Halt
20/12/17PRICE SENSITIVE
CGB Breakthrough for GMP Quality Medicinal Cannabis
11/12/17PRICE SENSITIVE
CGB South Johnstone Project Update
08/12/17PRICE SENSITIVE
CGB Australias largest hemp food production underway
07/12/17PRICE SENSITIVE
CGB VitaHemp Product Launch Australian Grown Goodness
27/11/17PRICE SENSITIVE
CGB Momentous Deal with Premium Hemp Processing Group
22/11/17PRICE SENSITIVE
CGB Results of AGM
15/11/17
CGB HISTORIC MOMENT FOR QBL
13/11/17PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
31/10/17PRICE SENSITIVE
CGB Anticipated Cashflow from MCL Investment
27/10/17PRICE SENSITIVE
CGB Engagement of Israeli Medical Cannabis Research Organisation
16/10/17PRICE SENSITIVE
CGB MDL Granted on South Johnstone Bauxite Project
16/10/17PRICE SENSITIVE
CGB Notice of Annual General Meeting/Proxy Form
11/10/17
CGB Response to ASX price and volume query
09/10/17PRICE SENSITIVE
CGB Notice of Issue of Performance Shares
04/10/17
CGB Annual Report to shareholders
29/09/17
CGB Appendix 4G
29/09/17
CGB Appendix 3B
29/09/17
CGB Preparing Major Launch of MCL's Quality Vitahemp Products
26/09/17PRICE SENSITIVE
CGB Unique Variations and High Levels of Cannabinoids Identified
19/09/17PRICE SENSITIVE
CGB MDL Work Programme Approved
13/09/17PRICE SENSITIVE
CGB Results of General Meeting
12/09/17
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.